Characterization of nifedipine solid dispersions
The sublingual administration of nifedipine (NIF) is currently used in clinical practice. The sublingual administration of NIF solid dispersions (SD), by using a suitable dispenser, appears an interesting approach in the treatment of moderate and severe hypertensive emergencies. With this aim nine S...
Saved in:
Published in | International journal of pharmaceutics Vol. 242; no. 1; pp. 313 - 317 |
---|---|
Main Authors | , , , |
Format | Journal Article Conference Proceeding |
Language | English |
Published |
Amsterdam
Elsevier B.V
21.08.2002
Elsevier |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | The sublingual administration of nifedipine (NIF) is currently used in clinical practice. The sublingual administration of NIF solid dispersions (SD), by using a suitable dispenser, appears an interesting approach in the treatment of moderate and severe hypertensive emergencies. With this aim nine SD made of NIF and a low viscosity hydroxypropylmethylcellulose (HPMC) in different ratio were prepared by means of spray-drying technique and their structure was studied. Moreover, the drug dissolution properties from SD were verified. The characteristic peaks of crystalline NIF were not detectable by using the X-ray analysis when the NIF/HPMC ratios were lower than 50/50 w/w. In thermograms obtained from SD, the NIF melting endothermic peak disappeared when NIF/HPMC ratios were lower than 30/70 w/w; the experimental
Tg values of SD were lower than the
Tg values predicted by Gordon Taylor equation suggesting some type of non-ideality of mixing. In the SD FTIR spectra the NH stretching vibrations and the CO stretch in esteric groups of NIF shift to free NH and CO regions indicating the rupture of intermolecular hydrogen bond in the crystalline structure of NIF. The prepared SD improved the NIF dissolution rate in comparison with that of commercial NIF or NIF/HPMC physical mixtures. Moreover, the concentration of NIF in the dissolution medium increased decreasing the NIF content. |
---|---|
AbstractList | The sublingual administration of nifedipine (NIF) is currently used in clinical practice. The sublingual administration of NIF solid dispersions (SD), by using a suitable dispenser, appears an interesting approach in the treatment of moderate and severe hypertensive emergencies. With this aim nine SD made of NIF and a low viscosity hydroxypropylmethylcellulose (HPMC) in different ratio were prepared by means of spray-drying technique and their structure was studied. Moreover, the drug dissolution properties from SD were verified. The characteristic peaks of crystalline NIF were not detectable by using the X-ray analysis when the NIF/HPMC ratios were lower than 50/50 w/w. In thermograms obtained from SD, the NIF melting endothermic peak disappeared when NIF/HPMC ratios were lower than 30/70 w/w; the experimental
Tg values of SD were lower than the
Tg values predicted by Gordon Taylor equation suggesting some type of non-ideality of mixing. In the SD FTIR spectra the NH stretching vibrations and the CO stretch in esteric groups of NIF shift to free NH and CO regions indicating the rupture of intermolecular hydrogen bond in the crystalline structure of NIF. The prepared SD improved the NIF dissolution rate in comparison with that of commercial NIF or NIF/HPMC physical mixtures. Moreover, the concentration of NIF in the dissolution medium increased decreasing the NIF content. The sublingual administration of nifedipine (NIF) is currently used in clinical practice. The sublingual administration of NIF solid dispersions (SD), by using a suitable dispenser, appears an interesting approach in the treatment of moderate and severe hypertensive emergencies. With this aim nine SD made of NIF and a low viscosity hydroxypropylmethylcellulose (HPMC) in different ratio were prepared by means of spray-drying technique and their structure was studied. Moreover, the drug dissolution properties from SD were verified. The characteristic peaks of crystalline NIF were not detectable by using the X-ray analysis when the NIF/HPMC ratios were lower than 50/50 w/w. In thermograms obtained from SD, the NIF melting endothermic peak disappeared when NIF/HPMC ratios were lower than 30/70 w/w; the experimental Tg values of SD were lower than the Tg values predicted by Gordon Taylor equation suggesting some type of non-ideality of mixing. In the SD FTIR spectra the NH stretching vibrations and the C=O stretch in esteric groups of NIF shift to free NH and C=O regions indicating the rupture of intermolecular hydrogen bond in the crystalline structure of NIF. The prepared SD improved the NIF dissolution rate in comparison with that of commercial NIF or NIF/HPMC physical mixtures. Moreover, the concentration of NIF in the dissolution medium increased decreasing the NIF content. |
Author | Montanari, L Casiraghi, A Minghetti, P Cilurzo, F |
Author_xml | – sequence: 1 givenname: F surname: Cilurzo fullname: Cilurzo, F email: francesco.cilurzo@unimi.it – sequence: 2 givenname: P surname: Minghetti fullname: Minghetti, P – sequence: 3 givenname: A surname: Casiraghi fullname: Casiraghi, A – sequence: 4 givenname: L surname: Montanari fullname: Montanari, L |
BackLink | http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=13891090$$DView record in Pascal Francis https://www.ncbi.nlm.nih.gov/pubmed/12176270$$D View this record in MEDLINE/PubMed |
BookMark | eNqFkMlKBDEQhoMozqKPoMxF0UNrZemk-yQyuMGAB_Uc0kk1Rnq6x6RH0Kc3s-AcPdUP9dXCNyL7bdciIScUrihQef0CXBVZThW_AHYJkEIm9siQFilwoeQ-Gf4hAzKK8QMAJKP8kAwoo0oyBUMC03cTjO0x-B_T-66ddPWk9TU6v_AtTmLXeDdxPi4wxNSOR-SgNk3E420dk7f7u9fpYzZ7fnia3s4yy0vaZ4ILlkvJubI5d4IjykqWCBXkFVMGqioVbpwpa8ytc5ZJY42wHIRAVuR8TM43exeh-1xi7PXcR4tNY1rsllErWhaqpGUC8w1oQxdjwFovgp-b8K0p6JUqvValVx40ML1WpUWaO90eWFZzdLuprZsEnG0BE61p6mBa6-OO40VJoVxxNxsOk44vj0FH67G1SWFA22vX-X9e-QXUGYa5 |
CODEN | IJPHDE |
CitedBy_id | crossref_primary_10_1517_17425247_2011_598147 crossref_primary_10_15436_2377_1313_16_020 crossref_primary_10_1016_j_carbpol_2020_115828 crossref_primary_10_3390_macromol3030026 crossref_primary_10_1007_s10973_011_1664_9 crossref_primary_10_1016_j_ijpharm_2012_08_031 crossref_primary_10_3109_03639045_2014_938080 crossref_primary_10_1208_s12249_009_9319_x crossref_primary_10_1007_s12247_022_09622_4 crossref_primary_10_3109_10837450_2016_1138130 crossref_primary_10_1080_03639045_2018_1503295 crossref_primary_10_1016_j_ijpharm_2012_12_020 crossref_primary_10_1016_j_ijpharm_2015_01_012 crossref_primary_10_1016_j_ijpharm_2022_121471 crossref_primary_10_1016_j_ijpharm_2019_118963 crossref_primary_10_1016_j_biopha_2017_10_161 crossref_primary_10_1016_j_carbpol_2013_08_046 crossref_primary_10_1016_j_jpba_2008_08_031 crossref_primary_10_3109_03639045_2012_685176 crossref_primary_10_18097_pbmc20105602187 crossref_primary_10_1016_j_molstruc_2022_134373 crossref_primary_10_1080_03639040500216097 crossref_primary_10_1080_03639040601179749 crossref_primary_10_1016_j_ijpharm_2005_05_014 crossref_primary_10_1093_jpp_rgab034 crossref_primary_10_1016_j_ijpharm_2020_119768 crossref_primary_10_1016_j_ijpharm_2006_11_029 crossref_primary_10_1016_j_ijpharm_2004_07_042 crossref_primary_10_3109_03639045_2012_692378 crossref_primary_10_1016_j_ijpharm_2005_12_007 crossref_primary_10_1007_s13318_019_00545_z crossref_primary_10_1021_mp900304p crossref_primary_10_1002_jps_20925 crossref_primary_10_1016_j_ijpharm_2022_122332 crossref_primary_10_1039_C6CE01645F crossref_primary_10_3390_ph15080993 crossref_primary_10_1016_j_ijpharm_2003_07_010 crossref_primary_10_1002_jps_10590 |
Cites_doi | 10.1111/j.1742-1241.1986.tb08036.x 10.1021/jm00186a029 10.1248/cpb.46.482 10.1111/j.2042-7158.1994.tb03776.x |
ContentType | Journal Article Conference Proceeding |
Copyright | 2002 Elsevier Science B.V. 2003 INIST-CNRS |
Copyright_xml | – notice: 2002 Elsevier Science B.V. – notice: 2003 INIST-CNRS |
DBID | IQODW CGR CUY CVF ECM EIF NPM AAYXX CITATION 7X8 |
DOI | 10.1016/S0378-5173(02)00173-4 |
DatabaseName | Pascal-Francis Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef MEDLINE - Academic |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef MEDLINE - Academic |
DatabaseTitleList | MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Pharmacy, Therapeutics, & Pharmacology |
EISSN | 1873-3476 |
EndPage | 317 |
ExternalDocumentID | 10_1016_S0378_5173_02_00173_4 12176270 13891090 S0378517302001734 |
Genre | Journal Article |
GroupedDBID | --- --K --M .GJ .~1 0R~ 1B1 1RT 1~. 1~5 29J 3O- 4.4 457 4G. 53G 5GY 5VS 7-5 71M 8P~ 9JM AABNK AACTN AAEDT AAEDW AAIAV AAIKJ AAKOC AALRI AAOAW AAQFI AAQXK AATCM AAXUO ABFNM ABFRF ABJNI ABMAC ABOCM ABXDB ABYKQ ABZDS ACDAQ ACGFO ACGFS ACIUM ACRLP ADBBV ADEZE ADMUD AEBSH AEFWE AEKER AENEX AFKWA AFTJW AFXIZ AGHFR AGUBO AGYEJ AHHHB AIEXJ AIKHN AITUG AJBFU AJOXV ALCLG ALMA_UNASSIGNED_HOLDINGS AMFUW AMRAJ ASPBG AVWKF AXJTR AZFZN BKOJK BLXMC C45 CS3 DU5 EBS EFJIC EFLBG EJD EO8 EO9 EP2 EP3 F5P FDB FEDTE FGOYB FIRID FNPLU FYGXN G-2 G-Q GBLVA HMT HVGLF HZ~ IHE J1W KOM M34 M41 MO0 N9A O-L O9- OAUVE OGGZJ OVD OZT P-8 P-9 P2P PC. Q38 R2- RIG ROL RPZ SCC SDF SDG SDP SES SEW SPCBC SPT SSP SSZ T5K TEORI WUQ ZXP ~02 ~G- AAPBV ABPIF ABPTK IQODW AAXKI AKRWK CGR CUY CVF ECM EIF NPM AAYXX AFJKZ CITATION 7X8 |
ID | FETCH-LOGICAL-c391t-4342566337c53d43ee6b69e0b05b27a0bbb273ada9fe5cddc26aca4c3044e2853 |
IEDL.DBID | .~1 |
ISSN | 0378-5173 |
IngestDate | Sat Oct 26 00:56:13 EDT 2024 Thu Sep 26 18:49:30 EDT 2024 Sat Sep 28 08:37:32 EDT 2024 Sun Oct 22 16:09:33 EDT 2023 Fri Feb 23 02:34:18 EST 2024 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 1 |
Keywords | Solid dispersion Sublingual administration Nifedipine HPMC Pharmaceutical technology Control release polymer Drug carrier In vitro Property formulation relationship Cellulose derivatives Dosage form Antihypertensive agent Active ingredient Dihydropyridine derivatives Release Physicochemical properties |
Language | English |
License | CC BY 4.0 |
LinkModel | DirectLink |
MeetingName | Selected papers from the 13th international symposium on microencapsulation, September 5-7, 2001, Angers, France |
MergedId | FETCHMERGED-LOGICAL-c391t-4342566337c53d43ee6b69e0b05b27a0bbb273ada9fe5cddc26aca4c3044e2853 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
PMID | 12176270 |
PQID | 71987919 |
PQPubID | 23479 |
PageCount | 5 |
ParticipantIDs | proquest_miscellaneous_71987919 crossref_primary_10_1016_S0378_5173_02_00173_4 pubmed_primary_12176270 pascalfrancis_primary_13891090 elsevier_sciencedirect_doi_10_1016_S0378_5173_02_00173_4 |
PublicationCentury | 2000 |
PublicationDate | 2002-08-21 |
PublicationDateYYYYMMDD | 2002-08-21 |
PublicationDate_xml | – month: 08 year: 2002 text: 2002-08-21 day: 21 |
PublicationDecade | 2000 |
PublicationPlace | Amsterdam |
PublicationPlace_xml | – name: Amsterdam – name: Netherlands |
PublicationTitle | International journal of pharmaceutics |
PublicationTitleAlternate | Int J Pharm |
PublicationYear | 2002 |
Publisher | Elsevier B.V Elsevier |
Publisher_xml | – name: Elsevier B.V – name: Elsevier |
References | Suzuki, Sunada (BIB4) 1998; 46 Erbel, Brand, Meyer, Efeert (BIB2) 1983; 59 Triggle, Shefter, Triggle (BIB5) 1980; 23 Abraham, Shukkur, Van Der Meulen, Johny (BIB1) 1986; 40 Save, Shah, Gharmande, Venkitachalam (BIB3) 1994; 46 Save (10.1016/S0378-5173(02)00173-4_BIB3) 1994; 46 Abraham (10.1016/S0378-5173(02)00173-4_BIB1) 1986; 40 Triggle (10.1016/S0378-5173(02)00173-4_BIB5) 1980; 23 Erbel (10.1016/S0378-5173(02)00173-4_BIB2) 1983; 59 Suzuki (10.1016/S0378-5173(02)00173-4_BIB4) 1998; 46 |
References_xml | – volume: 23 start-page: 1442 year: 1980 end-page: 1445 ident: BIB5 article-title: Crystal structure of calcium channel antagonists: 2,6-dimethyl-3,5-dicarbomethoxy-4-[2-nitro-, 3-cyano-, 4-(dimethylamino)-, and 2,3,4,5,6-pentafluorophenyl]-1,4-dihydropyridine publication-title: J. Med. Chem. contributor: fullname: Triggle – volume: 46 start-page: 482 year: 1998 end-page: 487 ident: BIB4 article-title: Influence of water-soluble polymers and the dissolution of nifedipine solid dispersion with combined carriers publication-title: Chem. Pharm. Bull. contributor: fullname: Sunada – volume: 59 start-page: 134 year: 1983 end-page: 136 ident: BIB2 article-title: Emergency treatment of hypertensive crisis with sublingual nifedipine publication-title: Med. J. contributor: fullname: Efeert – volume: 46 start-page: 192 year: 1994 end-page: 195 ident: BIB3 article-title: Comparative study of buccoadesive formulations and sublingual capsules of nifedipine publication-title: J. Pharm. Pharmacol. contributor: fullname: Venkitachalam – volume: 40 start-page: 478 year: 1986 end-page: 481 ident: BIB1 article-title: Sublingual nifedipine—a save and simple therapy for hypertensive emergencies publication-title: Br. J. Clin. Pract. contributor: fullname: Johny – volume: 40 start-page: 478 year: 1986 ident: 10.1016/S0378-5173(02)00173-4_BIB1 article-title: Sublingual nifedipine—a save and simple therapy for hypertensive emergencies publication-title: Br. J. Clin. Pract. doi: 10.1111/j.1742-1241.1986.tb08036.x contributor: fullname: Abraham – volume: 23 start-page: 1442 year: 1980 ident: 10.1016/S0378-5173(02)00173-4_BIB5 article-title: Crystal structure of calcium channel antagonists: 2,6-dimethyl-3,5-dicarbomethoxy-4-[2-nitro-, 3-cyano-, 4-(dimethylamino)-, and 2,3,4,5,6-pentafluorophenyl]-1,4-dihydropyridine publication-title: J. Med. Chem. doi: 10.1021/jm00186a029 contributor: fullname: Triggle – volume: 46 start-page: 482 year: 1998 ident: 10.1016/S0378-5173(02)00173-4_BIB4 article-title: Influence of water-soluble polymers and the dissolution of nifedipine solid dispersion with combined carriers publication-title: Chem. Pharm. Bull. doi: 10.1248/cpb.46.482 contributor: fullname: Suzuki – volume: 59 start-page: 134 issue: Suppl. 3 year: 1983 ident: 10.1016/S0378-5173(02)00173-4_BIB2 article-title: Emergency treatment of hypertensive crisis with sublingual nifedipine publication-title: Med. J. contributor: fullname: Erbel – volume: 46 start-page: 192 year: 1994 ident: 10.1016/S0378-5173(02)00173-4_BIB3 article-title: Comparative study of buccoadesive formulations and sublingual capsules of nifedipine publication-title: J. Pharm. Pharmacol. doi: 10.1111/j.2042-7158.1994.tb03776.x contributor: fullname: Save |
SSID | ssj0006213 |
Score | 1.9575822 |
Snippet | The sublingual administration of nifedipine (NIF) is currently used in clinical practice. The sublingual administration of NIF solid dispersions (SD), by using... |
SourceID | proquest crossref pubmed pascalfrancis elsevier |
SourceType | Aggregation Database Index Database Publisher |
StartPage | 313 |
SubjectTerms | Administration, Sublingual Antihypertensive agents Biological and medical sciences Calcium Channel Blockers - chemistry Cardiovascular system Crystallography, X-Ray Differential Thermal Analysis Excipients General pharmacology HPMC Lactose - analogs & derivatives Medical sciences Methylcellulose - analogs & derivatives Nifedipine Nifedipine - chemistry Oxazines Pharmaceutical technology. Pharmaceutical industry Pharmacology. Drug treatments Solid dispersion Solubility Spectroscopy, Fourier Transform Infrared Sublingual administration |
Title | Characterization of nifedipine solid dispersions |
URI | https://dx.doi.org/10.1016/S0378-5173(02)00173-4 https://www.ncbi.nlm.nih.gov/pubmed/12176270 https://search.proquest.com/docview/71987919 |
Volume | 242 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LSwMxEB6kXgQR39ZHzUFEodumyb5ylGKpiiJoobeweSz0si22Hrz4281kty49FMHTQthkwzfZmUky8w3AVYZGgWPME7dug8LDKFBG2CBNVWwVUqB7KqXnl3g4Ch_H0XgD-stcGAyrrHR_qdO9tq5auhWa3dlk0n2j3BeW5xTDghKOnKBItuXWdOe7DvOIWVUi2e2W8O06i6ccwTfeUHbrBwnCdfZpe5bNHWp5We5ivT_q7dJgF3Yqh5LclXPegw1b7MP1a8lI_dUm73WC1bxNrslrzVX9dQC0_0vYXOZjkmlOMNzFYE1rS9zKnBhiJsgnjudq80MYDe7f-8OgKqIQaC56C4TfeTUx54mOuAm5tbGKhaWKRoolGVXKPXhmMpHbSBujWZzpLNSchqFlzpgfQaOYFvYEiEm1G0v3qMjdrtJGKUuU4UYpYSIW5boJnSV0clZyZcg6iMxhLRFrSZn0WMuwCekSYLkidOn0-V9dWysCqT-IF69U0CZcLiUk3R-D1yBZYaefc5ngOYvoiSYcl4Kr-7r9WcwSevr_eZ3Blq8XQ53-6Z1DY_HxaS-c27JQLb8uW7B59_A0fPkBkZvl9w |
link.rule.ids | 310,311,315,783,787,792,793,4511,23944,23945,24130,25154,27938,27939,45599,45693 |
linkProvider | Elsevier |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LSwMxEB60HhREfLs-c5Ci0G3TJPvIUYpStRXBFnoLm8dCL22x9eDF326S3bp4KIKnhbDJhm-yM5Nk5huA68wZBepinqixGxTKolBqbsI0lbGRjgLdUyn1X-LukD2NotEadJa5MC6sstT9hU732rpsaZVotmbjcesNU19YnmIXFpRQtg4bzPFn2UXd_KriPGJS1ki22yX3epXGUwzhG28wufWjhGyVgdqeZXMLW17Uu1jtkHrD9LALO6VHie6KSe_BmpnsQ_21oKT-bKBBlWE1b6A6eq3Iqj8PAHd-GJuLhEw0zZGLd9GuqLVBdmmONdJjRyjuDtbmhzB8uB90umFZRSFUlLcXDn_r1sSUJiqimlFjYhlzgyWOJEkyLKV90ExnPDeR0lqROFMZUxQzZoi15kdQm0wn5gSQTpUdS7Uxz-220kQpSaSmWkquIxLlKoDmEjoxK8gyRBVFZrEWDmuBifBYCxZAugRY_JK6sAr9r66XvwRSfdDdvGKOA7haSkjYX8bdg2QTM_2Yi8QdtPA2D-C4EFzV127QYpLg0__P6wo2u4N-T_QeX57PYMsXj8FWGbXPobZ4_zAX1odZyEu_Rr8BHSDnmQ |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=proceeding&rft.title=International+journal+of+pharmaceutics&rft.atitle=Characterization+of+nifedipine+solid+dispersions&rft.au=CILURZO%2C+F&rft.au=MINGHETTI%2C+P&rft.au=CASIRAGHI%2C+A&rft.au=MONTANARI%2C+L&rft.date=2002-08-21&rft.pub=Elsevier&rft.issn=0378-5173&rft.eissn=1873-3476&rft.volume=242&rft.issue=1-2&rft.spage=313&rft.epage=317&rft_id=info:doi/10.1016%2FS0378-5173%2802%2900173-4&rft.externalDBID=n%2Fa&rft.externalDocID=13891090 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0378-5173&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0378-5173&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0378-5173&client=summon |